GSK vs OFIX · P/E 13, $103.31B cap vs rev $407.6M
GlaxoSmithKline PLC ADR (GSK) versus Orthofix Medical Inc (OFIX) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Orthofix Medical Inc (OFIX) is a medical devices company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported OFIX revenue for 2026-06-30 was $407.6M. Net income was -$36.7M. OFIX currently screens at market cap $438.0M.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. OFIX currently screens at market cap $438.0M.
Not investment advice. Open the GSK and OFIX stock pages for the full models.
Not investment advice.